黑龙江医学
黑龍江醫學
흑룡강의학
Heilongjiang Medical Journal
2015年
9期
1046-1048
,共3页
前列腺癌,前列腺增生组织%血管内皮生长因子%环氧化酵素二型
前列腺癌,前列腺增生組織%血管內皮生長因子%環氧化酵素二型
전렬선암,전렬선증생조직%혈관내피생장인자%배양화효소이형
Prostate cancer%Benign prostatic hyperplasia tissue%VEGF%COX-2
目的:通过检测VEGF和COX-2在前列腺癌组织及前列腺增生组织中的表达情况,从而探讨两者与前列腺癌发生发展的关系。方法采用免疫组化SP方法检测前列腺癌组织及前列腺增生组织中两者的表达情况,比较两者在两种不同组织中的表达情况。结果前列腺癌组织中,VEGF的表达阳性率为64.00%(32/50),在前列腺增生组织中VEGF的表达阳性率为15.0%(3/20),VEGF在前列腺癌组织及前列腺增生组织中表达阳性率差异性显著(P<0.05);COX-2在前列腺癌组织中的表达阳性率为68.00%(34/50),在前列腺增生组织中的阳性表达率为20.00%(4/20),COX-2在前列腺癌组织及前列腺增生组织中表达阳性率差异性显著( P<0.05);VEGF的表达水平与肿瘤的分化程度、临床分期密切相关;COX-2与肿瘤的临床分期相关,但是与分化程度无明显关系。结论 VEGF与COX-2与前列腺癌的发生及发展密切相关,通过检测VEGF与COX-2的表达水平预测前列腺癌患者的预后情况,为临床上治疗前列腺癌提供一定的理论根据,因此也可以为临床上对前列腺癌的后续治疗提供一定的指导方法。
目的:通過檢測VEGF和COX-2在前列腺癌組織及前列腺增生組織中的錶達情況,從而探討兩者與前列腺癌髮生髮展的關繫。方法採用免疫組化SP方法檢測前列腺癌組織及前列腺增生組織中兩者的錶達情況,比較兩者在兩種不同組織中的錶達情況。結果前列腺癌組織中,VEGF的錶達暘性率為64.00%(32/50),在前列腺增生組織中VEGF的錶達暘性率為15.0%(3/20),VEGF在前列腺癌組織及前列腺增生組織中錶達暘性率差異性顯著(P<0.05);COX-2在前列腺癌組織中的錶達暘性率為68.00%(34/50),在前列腺增生組織中的暘性錶達率為20.00%(4/20),COX-2在前列腺癌組織及前列腺增生組織中錶達暘性率差異性顯著( P<0.05);VEGF的錶達水平與腫瘤的分化程度、臨床分期密切相關;COX-2與腫瘤的臨床分期相關,但是與分化程度無明顯關繫。結論 VEGF與COX-2與前列腺癌的髮生及髮展密切相關,通過檢測VEGF與COX-2的錶達水平預測前列腺癌患者的預後情況,為臨床上治療前列腺癌提供一定的理論根據,因此也可以為臨床上對前列腺癌的後續治療提供一定的指導方法。
목적:통과검측VEGF화COX-2재전렬선암조직급전렬선증생조직중적표체정황,종이탐토량자여전렬선암발생발전적관계。방법채용면역조화SP방법검측전렬선암조직급전렬선증생조직중량자적표체정황,비교량자재량충불동조직중적표체정황。결과전렬선암조직중,VEGF적표체양성솔위64.00%(32/50),재전렬선증생조직중VEGF적표체양성솔위15.0%(3/20),VEGF재전렬선암조직급전렬선증생조직중표체양성솔차이성현저(P<0.05);COX-2재전렬선암조직중적표체양성솔위68.00%(34/50),재전렬선증생조직중적양성표체솔위20.00%(4/20),COX-2재전렬선암조직급전렬선증생조직중표체양성솔차이성현저( P<0.05);VEGF적표체수평여종류적분화정도、림상분기밀절상관;COX-2여종류적림상분기상관,단시여분화정도무명현관계。결론 VEGF여COX-2여전렬선암적발생급발전밀절상관,통과검측VEGF여COX-2적표체수평예측전렬선암환자적예후정황,위림상상치료전렬선암제공일정적이론근거,인차야가이위림상상대전렬선암적후속치료제공일정적지도방법。
Objective To detect VEGF and COX-2 in prostate cancer and benign prostatic hyperplasia tissues , and thereby to explore the relationship between the development of prostate cancer.Methods Immunohistochemical SP method was used to detect prostate cancer and benign prostatic hyperplasia tissue expression , and the expression of both was compared in the two different tissues.Results In pros-tate cancer, VEGF expression positive rate was 64.00% (32/50).In BPH tissue, VEGF expression positive rate was 15.0% (3/20).There was significantly difference in positive rate of VEGF expression in prostate cancer and benign prostatic hyperplasia tissue ( P<0.05).COX-2 in prostate cancer tissue expression was 68.00%(34/50).The positive expression in benign prostatic hyperplasia tis-sue was 20.00%(4/20).In COX-2 expression in prostate cancer and benign prostatic hyperplasia , the positive rate was significantly difference ( P<0.05 ).The expression of VEGF was closely related with tumor differentiation and TNM stage.COX-2 was correlated with the clinical stage of the tumor , but there was no significant relationship between the degrees of differentiation.Conclusion VEGF and COX-2 is closely related to the occurrence and development of prostate cancer by detecting the expression of VEGF and COX -2 in predic-ting the prognosis of patients with prostate cancer to provide theoretical basis for the clinical treatment of prostate cancer , and therefore it may provide some guidance methods of clinical follow -up treatment for prostate cancer.